A essential problem for regulators including the HRA, and perhaps the medical community in general, is to know when and the way to re-analyze very long standing viewpoints or dogmas. Exactly when ought to anecdotal evidence from sometimes really vocal client teams be tested in time consuming and high-priced scientific trials?At a similar time, Glob